Expanding Vision Care: Newton™ Introduces Sequel™ Lenses

Expanding Vision Care Solutions with Sequel™ Lenses

Where comfort and clarity converge. Sequel democratizes premium everyday lenses through VSP®.

Newton™ is excited to announce that its innovative Sequel™ everyday lens is now included in VSP's managed vision care plan. This inclusion makes the unique Convergence Boost™ technology accessible to millions of individuals navigating a screen-centric lifestyle, which can often lead to digital eye strain.

Understanding Digital Eye Strain and Sequel™

Digital eye strain has become increasingly prevalent, affecting up to 75% of individuals who frequently use devices. With this in mind, Sequel™ stands apart by integrating Convergence Boost technology aimed at providing exceptional visual comfort and clarity tailored for the demands of modern-day usage.

Research indicates a remarkable 91% of Sequel™ wearers have experienced a significant reduction in common symptoms associated with digital eye strain, with 80% recommending it enthusiastically.

Empowering Optometrists with Innovative Solutions

Sequel™ also empowers optometric practices within the VSP network, offering them a valuable differentiator in managing visual fatigue among patients. This lens is designed for easy dispensing and aims to deliver impactful results for all who struggle with eye strain.

A Bold Step in Vision Care

As a leader in eye care innovation, Newton™ is expanding its vision care offerings with Sequel™, which addresses the widespread issues of digital eye strain. The portfolio encompasses various designs including Sequel 0, 38, 67, and PAL, ensuring that every patient struggling with visual discomfort can benefit from the advanced Convergence Boost technology.

Patient-Centric Design and Impact

Speaking about Sequel™, CEO Davis Corley shared, "Sequel is the lens patients didn't know they needed—but won't want to go without. By making it available through VSP, we are democratizing access to innovative technology that meets today's visual lifestyle demands. This partnership removes barriers and allows life-changing vision solutions to reach millions of individuals."

Insights from Eye Care Professionals

Dr. Paul Lovero, an optometrist who has fitted Sequel™, commented, "With Sequel™, my patients express that their eyes feel relaxed and free from strain. The simplicity of fitting makes it a seamless addition to my practice and is exactly what modern patients need."

This collaboration not only expands patient options but also reinforces Newton™'s commitment to improving health tech and patient outcomes. By including Sequel™ in VSP, advanced solutions to digital eye strain are made increasingly accessible.

About Newton™ and Its Innovations

Newton™ is an innovative company transforming eye care through superior patient experiences and outcomes. With its proprietary Contoured Prism technology exclusive to the Neurolens portfolio and the newly launched Sequel™ lenses, Newton™ equips eye care providers with tools to deliver significant relief to patients while raising the standard of care in the industry.

For more information about Sequel™ and ways to enhance your practice through VSP, visit www.sequellens.com.

Frequently Asked Questions

What is Sequel™ Lens Technology?

Sequel™ utilizes Convergence Boost technology to combat digital eye strain, enhancing comfort for users through innovative lens design.

How does Sequel™ differ from traditional lenses?

Unlike traditional lenses, Sequel™ is specifically designed to address digital eye strain, providing improved clarity for screen use and overall vision quality.

Can Sequel™ be used for all types of vision problems?

Yes, Sequel™ is available in various designs suitable for different visual requirements, making it adaptable for a wide range of patients.

What are the reported benefits of wearing Sequel™ lenses?

Patients have reported significant relief from symptoms of digital eye strain, with high satisfaction rates and recommendations following use of Sequel™ lenses.

How can I learn more about incorporating Sequel™ in my practice?

For more information on how to include Sequel™ in your practice, please visit www.sequellens.com for resources and details.

About The Author

My name is Dylan Bailey, and I am 28 years old. I am an author and an expert on the stock market who specializes in publicly traded companies. Early fascination with the stock market inspired me to seek a finance degree and then delve deeply into the world of stocks. I have developed over the years my abilities to spot investment prospects, assess business performance, and analyze market trends.

My books and articles try to help regular investors understand the nuances of the stock market. Anyone can, in my opinion, make wise investment choices and succeed financially if they have the correct information and resources. In my writing, I combine in-depth research with practical insights and advice that can be put into action. This is done with the intention of assisting readers in navigating the constantly shifting landscape of publicly traded companies.

In addition to writing, I also host webinars and workshops, where I give presentations and share my knowledge with a wider audience. I also write for top financial journals and show up as a guest analyst on financial news shows. I like to travel, spend time with my family, and keep active by playing different sports when I'm not buried in market research.

My goal is to enable people to choose wisely and consciously in their investments, so taking charge of their financial futures. By my work, I hope to create a community of informed and self-assured investors prepared to take advantage of the chances presented by the stock market.

Contact Dylan Bailey privately here. Or send an email with ATTN: Dylan Bailey as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.